Global Bio-chem Technology Group Company Limited
GBCMF
$0.005
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 70.91M | 70.68M | 57.47M | 57.45M | 57.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 70.91M | 70.68M | 57.47M | 57.45M | 57.92M |
| Cost of Revenue | 61.09M | 60.90M | 53.25M | 53.23M | 51.40M |
| Gross Profit | 9.82M | 9.79M | 4.22M | 4.22M | 6.52M |
| SG&A Expenses | 11.74M | 11.70M | 10.99M | 10.98M | 13.91M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -3.37M | -3.36M | 3.35M | 3.35M | -7.65M |
| Total Operating Expenses | 69.46M | 69.24M | 67.59M | 67.56M | 57.66M |
| Operating Income | 1.45M | 1.45M | -10.12M | -10.11M | 252.40K |
| Income Before Tax | 58.10M | 57.91M | -10.09M | -10.09M | 240.68M |
| Income Tax Expenses | -1.54M | -1.54M | -- | -- | -739.10K |
| Earnings from Continuing Operations | 59.64M | 59.45M | -10.09M | -10.09M | 241.41M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 34.99M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -1.93M |
| Net Income | 59.64M | 59.45M | -10.09M | -10.09M | 274.47M |
| EBIT | 1.45M | 1.45M | -10.12M | -10.11M | 252.40K |
| EBITDA | 6.95M | 6.93M | -1.98M | -1.98M | 8.67M |
| EPS Basic | 0.01 | 0.01 | 0.00 | 0.00 | 0.03 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 8.95B | 8.95B | 8.91B | 8.91B | 8.91B |
| Average Diluted Shares Outstanding | 43.49B | 43.49B | 8.91B | 8.91B | 19.25B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |